Ibverine Tablet contains Mebeverine 135 mg, an antispasmodic agent primarily used to relieve symptoms associated with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. Mebeverine acts directly on the smooth muscle of the gastrointestinal tract, exerting a spasmolytic effect without altering normal gut motility. This action helps alleviate abdominal pain, cramps, and discomfort caused by intestinal spasms. Ibverine is indicated for the symptomatic treatment of conditions such as IBS, diverticulitis, and other spastic colonic disorders. The tablet should be administered orally, typically before meals, as directed by a healthcare professional. It is generally well tolerated, with a low incidence of adverse effects; however, some patients may experience mild gastrointestinal disturbances, headache, or allergic reactions. Ibverine is contraindicated in individuals with known hypersensitivity to Mebeverine or any excipients in the formulation. Caution is advised in patients with severe liver or kidney impairment. This medication should be used under medical supervision, especially in pregnant or lactating women, until further safety data are available. Proper diagnosis and adherence to prescribed dosage ensure optimal therapeutic outcomes in managing gastrointestinal spasms and associated symptoms.